Purpose: To describe results of AFX unibody stent-graft treatment for TransAtlantic Inter-Society Consensus (TASC) D aortoiliac occlusive disease (AIOD) with coexistent abdominal aortic aneurysm (AAA).
Methods: A retrospective analysis was conducted of 21 consecutive patients (mean age 73.6±6.4 years; 17 men) with TASC D AIOD plus AAA (diameter >3.5 cm) treated electively using the AFX stent-graft. Common iliac artery (CIA) and external iliac artery (EIA) stenosis or occlusion was reported. Outcome measures were technical and clinical success, improvement in ankle-brachial index (ABI), and improvement in Rutherford category. Immediate and midterm patency, AAA exclusion, major adverse events (MAE), and mortality were also evaluated.
Results: After AFX deployment (100% technical success), 18 EIAs required adjunctive stenting (none required in the CIA). One patient required a reintervention for closure device failure. At 30-day follow-up, no death or MAE was recorded. Improvement in ABI was registered in all patients (mean 0.91±0.11), with 100% primary patency. At a mean follow-up of 25.2±11.1 months, primary patency was maintained in all cases. No death or amputation occurred; 2 patients had a myocardial infarction. Improvement in ABI was maintained (0.88±0.13) as well as Rutherford category.
Conclusion: This study examined the use of the AFX unibody stent-graft for the treatment of TASC D AIOD with concomitant AAA. The AFX stent-graft appears to be a safe and effective solution for these complex lesions, with low morbidity and mortality.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/1526602817730840 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Do Not Mix It up! Long-Term Outcomes of Different Proximal Aortic Cuffs with the AFX Endograft.
Ann Vasc Surg
November 2024
Department of Public Health, Vascular Surgery Unit, University Federico II of Naples, Naples, Italy.
Background: The AFX unibody endograft offers advantages in treating abdominal aortic aneurysms (AAAs) with narrow aortic bifurcations due to its unique design, where the flow divider sits at the native aortic bifurcation. However, its limited length options may limit complete proximal neck utilization. As per device instruction for use, the implant should be completed with an aortic cuff.
View Article and Find Full Text PDFEndovascular abdominal aortic aneurysm repair (EVAR) outcomes of unibody and single/double docking limb endografts in Medicare beneficiaries between 2012 and 2018.
Vascular
November 2024
Endologix LLC, Irvine, CA, USA.
Objective: The evaluation of perioperative and long term outcomes for endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAA) using anatomic (unibody) and proximal neck fixated (docking limbs) endografts across consecutive time cohorts.
Design: This study compares the outcomes of EVAR in Medicare patients stratified by mode of fixation.
Methods: All patients who underwent EVAR between 2012 and 2018 were identified in the Medicare database.
Bifurcated Endografts for the Treatment of Aortoiliac Disease a Systematic Review and Individual Patient Data (IPD) Meta-Analysis.
J Endovasc Ther
October 2024
Department of Vascular Surgery, AHEPA University General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Article Synopsis
- This review evaluated the effectiveness and safety of bifurcated endografts for treating aortoiliac disease (AOID) by analyzing multiple studies across various databases.* -
- Ten studies involving 365 patients primarily used the AFX endograft, showing high primary patency rates at 12, 24, and 36 months, with estimates around 90-94% and low rates of major complications.* -
- While the initial findings suggest that bifurcated endografts are a promising option for AOID treatment, further research is needed to conclusively determine their long-term efficacy and safety.*
Safety Evaluation of Unibody Endografts for Abdominal Aortic Aneurysm Repair: A Systematic Review and Meta-Analysis.
Ann Vasc Surg
November 2024
Faculty of Medicine, Vascular and Endovascular Surgery Unit, Alexandria University, Alexandria, Egypt.
Background: The unibody bifurcated aortic endograft (AFX/AFX2) has emerged as a treatment option for abdominal aortic aneurysms (AAAs). This systematic review and meta-analysis aimed to evaluate the safety of the unibody endograft.
Methods: A literature search was conducted in Cochrane Library, Scopus, Web of Science, and PubMed.
AFX unibody stent graft: Effective and safe for the treatment of severe aorto-iliac occlusive disease.
Vascular
October 2024
Department of Vascular Surgery, Royal North Shore Hospital, Sydney, Australia.
Objectives: The primary objective of this study was to determine the primary, assisted primary and secondary patency rates of the Endologix AFX stent-graft in patients considered high risk for open surgery with complex aorto-iliac occlusive disease. The secondary objective was to determine 30-day major adverse cardiovascular and cerebrovascular events.
Methods: A retrospective review was undertaken of clinical records of 38 patients who underwent AFX stent-graft placement for aorto-iliac occlusive disease from 2016 to 2019.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!